Advertisements


Mylan to have only a "minor" delay to generic Advair approval, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Even minor delays can hurt Mylan"s generic Advair opportunity, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Mylan (MYL) to Get CRL Again for Generic Advair from FDA

Mylan (MYL) suffers another setback with its ANDA for Advair as the FDA refuses to approve the same, due to minor deficiencies. Shares of Myla.....»»

Category: smallbizSource: nytJun 14th, 2018

Technical Take: Mylan falls after FDA says generic Advair has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Advair generic delay negative news for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Morgan Stanley says generic Advair delay a small negative for Mylan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan to recover from "modest" generic Advair delay, says Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan falls 4.5% after FDA says generic Advair Diskus has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

FDA says Mylan"s generic Advair Diskus has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis.....»»

Category: topSource: seekingalphaJun 13th, 2018

Biocon 483 letter won"t delay approval of Mylan"s Neulasta, says Bernstein

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

FDA approves first generic version of EpiPen

The U.S. Food and Drug Administration has approved the first generic version of Mylan's EpiPen, made by Teva Pharmaceuticals, which could could help lower the cost of the life-saving allergy injection. Linda So reports......»»

Category: videoSource: reutersAug 18th, 2018

H.C. Wainwright ups Antares price target to $4.50 after generic EpiPen approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 17th, 2018

Antares Pharma and Teva granted FDA approval of generic EpiPen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

FDA announces approval of first generic EPiPen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Teva Wins FDA Approval For Generic Epinephrine

After nearly two years, the U.S. Food & Drug Administration has finally approved the generic versions of the EpiPen produced by Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA). read more.....»»

Category: blogSource: benzingaAug 16th, 2018

Teva"s earlier than expected generic EpiPen bad news for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Are Teva and Mylan Entering an EpiPen Price War to Zero?

Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it......»»

Category: blogSource: 247wallstAug 16th, 2018

FDA approves first generic EpiPen in blow to Mylan

The EpiPen is getting competition. The Food and Drug Administration has approved what it described as the first official generic version of the EpiPen, a life-saving treatment for severe allergic reactions.....»»

Category: topSource: usatodayAug 16th, 2018

Teva granted FDA approval of first generic version of EpiPen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Teva rises, Mylan dips after FDA reported to approve first generic EpiPen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018